Archive for the ‘research’ Category

Advances in Lyme & Babesiosis Research

https://www.globallymealliance.org/news/from-diagnostics-to-disease-mechanisms-advances-in-lyme-and-babesiosis-research?

From Diagnostics to Disease Mechanisms: Advances in Lyme and Babesiosis Research

by Cara DeAngelis, Ph.D. on January 3, 2025

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >From Diagnostics to Disease Mechanisms: Advances in Lyme and Babesiosis Research</span>
Cutting-edge research funded by GLA advances diagnostics and insights into Lyme disease and babesiosis, identifying key biomarkers and genetic risk factors.

Three GLA-funded investigators have been making exciting progress. Dr. Rafal Tokarz’s team has been uncovering key insights into the immune response to specific proteins of Lyme bacteria, paving the way for more accurate diagnostics. Dr. Ben Mamoun has achieved an important milestone by developing the first diagnostic tests for detecting active Babesia duncani infections.  Dr. Klemen Strle’s research suggests that specific genetic factors may increase the risk of developing chronic Lyme arthritis. Meanwhile, Dr. Strle’s new findings are shedding light on how certain genetic factors may heighten the risk of developing chronic Lyme arthritis. 

Summary: 

GLA-funded research continues to shed light on key aspects of Lyme and tick-borne diseases, from diagnostic biomarkers to genetic factors influencing disease outcomes. 

Dr. Rafal Tokarz and his team at Columbia University used peptide arrays and machine learning to identify immune reactive proteins in Borrelia burgdorferi to differentiate between phases of Lyme disease. These insights could enhance the accuracy of antibody-based diagnostic tests by improving their sensitivity and specificity (Tokarz et al., 2024). 

At Yale University, Dr. Choukri Ben Mamoun and his team developed the first antigen detection tests for Babesia duncani, a parasite often responsible for severe babesiosis. These assays, validated with over 1,700 samples, can detect active infections with high sensitivity and specificity, paving the way for early diagnosis, reservoir animal screening, and improved blood safety (Chand et al., 2024).  

Research by Dr. Klemen Strle and his group at Tufts University identified genetic variations associated with chronic Lyme arthritis. These variations are linked to increased inflammation and autoantibody responses, suggesting that some patients may have a genetic predisposition to persistent arthritis in Lyme disease. These findings may guide future biomarker development to predict disease risk (Ehrbar et al., 2024). 

These studies reflect GLA’s unwavering commitment to support research that addresses critical challenges in diagnosing and managing tick-borne diseases. 

Publications: 

Tokarz, R., Guo, C., Sanchez-Vicente, S., Horn, E., Eschman, A., Turk, S. P., Lipkin, W. I., & Marques, A. (2024). Identification of reactive Borrelia burgdorferi peptides associated with Lyme disease. mBio, 15(10). https://doi.org/10.1128/mbio.02360-24   

Chand, M., Vydyam, P., Pal, A. C., Thekkiniath, J., Darif, D., Li, Z., Choi, J. Y., Magni, R., Luchini, A., Tonnetti, L., Horn, E. J., Tufts, D. M., & Ben Mamoun, C. (2024). A set of diagnostic tests for detection of active Babesia duncani infection. International Journal of Infectious Diseases, 147, 107178. https://doi.org/10.1016/j.ijid.2024.107178  

Ehrbar, D., Arvikar, S. L., Sulka, K. B., Chiumento, G., Nelson, N. L. J., Hernandez, S. A., Williams, M. A., Strle, F., Steere, A. C., & Strle, K. (2024). Variants in the late cornified envelope gene locus are associated with elevated T-helper 17 responses in patients with postinfectious Lyme arthritis. The Journal of Infectious Diseases, 230(Supplement_1), S40–S50. https://doi.org/10.1093/infdis/jiae164  

https://www.globallymealliance.org/news/decoding-chronic-lyme-investigating-epigenetic-signatures?

Decoding Chronic Lyme: Investigating Epigenetic Signatures

by Admin at Global Lyme Alliance on January 3, 2025

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Decoding Chronic Lyme: Investigating Epigenetic Signatures</span>
Pictured: Tanja Petnicki-Ocwieja, PhD, courtesy of Tufts University School of Medicine
Tufts University, with support from GLA, is leading research to uncover epigenetic mechanisms behind chronic Lyme disease. Dr. Tanja Petnicki-Ocwieja’s work could improve treatments and reveal commonalities with other post-infectious syndromes like long COVID.

By Mase Peterson

In the fight against Lyme disease, cutting-edge research is essential for advancing treatment and prevention strategies. Tanja Petnicki-Ocwieja, PhD, a research assistant professor at Tufts University School of Medicine, is a key contributor to this effort through her work with the Tufts Lyme Disease Initiative. This collaborative group of faculty, staff, and students is dedicated to eliminating the public health threat of Lyme disease by 2030.

Tufts is home to one of the world’s most comprehensive groups of tick-borne disease researchers. Led by co-directors Linden Hu, Paul and Elaine Chervinsky Professor of Immunology, and Robert P. Smith, a physician at Maine Medical Center and professor of medicine, the team recently secured a $20.7 million federal grant, further solidifying Tufts’ position as a global leader in Lyme disease research.

In this Q&A, part of a feature series spotlighting members of the Initiative, Professor Petnicki-Ocwieja discusses her research on the immunological and epigenetic mechanisms underlying chronic Lyme disease and its potential to transform patient outcomes…

Read the rest from Tufts School of Medicine

_____________

**Comment**

I’d love to be hopeful, but when the moniker PTLDS continues to be used it shows an inherent bias that ongoing infections aren’t to blame for people’s ongoing symptoms.  This must change.

For more:

Category:

Babesia, Lyme, research, Uncategorized

Lyme Disease Research in Review: Triumphs, Trials, and the Path Forward

https://www.lymedisease.org/lyme-disease-research-review/

Lyme disease research in review: triumphs, trials, and the path forward

As always, the world of Lyme is complicated with both good news and bad. Looking back over the past year, I want to highlight a few of the biggest scientific advances that stand out in my mind.

Co-Infections

First I want to share something that science keeps validating—the majority of patients with persistent symptoms following a diagnosis of Lyme disease have co-infections.

This means they are infected with two or more pathogens (such as bacteria, viruses, or fungi) at the same time. These co-infections (including COVID-19) complicate the immune response and likely increase the chance of developing chronic Lyme.

As I wrote about previously, North America is “ground zero” for babesiosis, which is likely playing a much greater role in patients with chronic Lyme than we know. In the MyLymeData study, over 60% of patients report they were diagnosed with an additional tick-borne infection along with Lyme. For most of them, it’s Babesia.

In July 2024, researchers conducting a Lyme disease pilot study at North Carolina State University discovered that all seven participants were infected with Babesia, and six out of the seven were co-infected with at least one (sometimes two or more) species of Bartonella.

Babesia is a parasite, similar to malaria. It requires a separate test and special anti-parasitic medications outside of the standard tests and antibiotics used for Lyme disease alone.

Diagnostics

As I wrote about in December 2023, Borrelia (Lyme) has some unique features allowing it to hide from our immune system. That stealth technique, which keeps the number of bacteria low in the blood stream, also makes it difficult for standard blood tests to detect Lyme disease. In April of 2024, Dr. Michal Tal and her team published another clue as to how Borrelia hides from the immune system.

Right now, all eyes are on the six teams competing in the LymeX diagnostic challenge as they move forward with their innovations. These will hopefully result in a more accurate test becoming available to the public than the standard outdated test that has been around since 1994. (Note: Lyme X Phase 3 winners will be announced soon.)

While an accurate Lyme diagnostic is absolutely needed, I cannot ignore the fact that ticks in North America are known to transmit over 18 different pathogens.

In August of 2024, a team of biologists at City University of New York Graduate Center produced a genetic analysis of 47 different strains of Borrelia. This may pave the way for improved diagnosis, treatment, and prevention of Lyme disease.

I hope that with this new genetic mapping, we will finally be able to take advantage of the next-generation metagenomic testing which is capable of detecting multiple pathogens.

Treatment

One of the top priorities of patients with chronic Lyme disease is finding an effective treatment.

Two recent studies have shown that combination therapy for Lyme, and combination therapy for Babesia work better than monotherapy.

But not everyone responds favorably to pharmaceuticals. One reason for this, may be a condition called alpha-gal syndrome (AGS).

AGS is triggered by the bite of a tick and causes an allergy to anything derived from red meats including some medications. An estimated 450,000 people have AGS in the U.S., making it the tenth most common food allergen.

If enacted, the Alpha-Gal Inclusion Act would require the FDA to list alpha-gal as a major allergen and require labeling to include it as an ingredient.

Mast cell activation syndrome

Another complicating factor common in patients with chronic Lyme is mast cell activation syndrome (MCAS). MCAS can make patients extremely sensitive to certain types of chemicals, foods and additives.

In fact, MCAS is such an important topic, in 2024 we devoted an entire issue of the Lyme Times to Mast Cell Activation Syndrome which you can download and read for free.

Alas, there is nothing simple about treating complex medical conditions triggered by the bite of a tick. Many of the patients I know who’ve gotten better took years before they found the root cause of their misery followed by the right combination of treatment that worked.

In 2023 we devoted an entire issue of the Lyme Times trying to answer the question: What does it take to get better?

My hope is that we continue to see scientific progress in finding better diagnostics and treatment. And if you are struggling with a chronic illness, please do not give up hope.

LymeSci is written by Lonnie Marcum, a physical therapist and mother of a daughter with Lyme. She served two terms on a subcommittee of the federal Tick-Borne Disease Working Group. Follow her on X: @LonnieRhea   Email her at: lmarcum@lymedisease.org.

_______________

**Comment**

To my knowledge, treating this complex illness has hardly moved forward in over 40 years.  The medical industrial complex is myopically focused on ‘vaccines,’ which are big money makers for both Big Pharma and the government, which owns patents on many aspects of them.  As long as this remains the singular focus, patients will not be treated properly.  Further, as long as ‘consensus based‘ medicine reigns, innovative doctors who dare to use their God-given brains to help patients will continue to be persecuted, leaving patients to suffer.  As it is, the only true help for Lyme/MSIDS is to get to an independent, trained, and experienced Lyme literate doctor.

For more:

Category:

Lyme, Mast Cell Activation Syndrome (MCAS), research, Testing, Ticks, Treatment

Optimizing Exclusion Criteria For Clinical Trials of Persistent Lyme Disease Using Real-World Data

https://www.mdpi.com/2227-9032/13/1/20

Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data

by Lorraine Johnson1, Mira Shapiro2, Deanna Needell3 and Raphael B. Stricker4,*
1LymeDisease.org, Los Angeles, CA 91040, USA
2Analytic Designers LLC, Bethesda, MD 20817, USA
3Department of Mathematics, University of California, Los Angeles, CA 90025, USA
4Union Square Medical Associates, 595 Buckingham Way, Suite 350, San Francisco, CA 94132, USA
*Author to whom correspondence should be addressed.
Healthcare 2025, 13(1), 20; https://doi.org/10.3390/healthcare13010020
Submission received: 15 October 2024 / Revised: 19 December 2024 / Accepted: 21 December 2024 / Published: 25 December 2024
(This article belongs to the Topic Public Health and Healthcare in the Context of Big Data)

Abstract

Background/Objectives: Although eligibility criteria for clinical trials significantly impact study outcomes, these criteria are often established without scientific justification, leading to delayed recruitment, small sample sizes, and limited study generalizability. Persistent Lyme disease (PLD) presents unique challenges due to symptom variability, inconsistent treatment responses, and the lack of reliable biomarkers, underscoring the need for scientifically justified eligibility criteria.
Objective: This study examines the effects of commonly used enrollment criteria on sample yield in PLD clinical trials using real-world data (RWD) from the MyLymeData patient registry. The study also compares the effects of these criteria on enrollment for PLD versus acute Lyme disease (ALD) trials and evaluates the scientific rationale for each criterion.
Methods: Data from 4183 Lyme disease patients enrolled in the MyLymeData registry were analyzed to assess the prevalence and cumulative impact of various criteria on sample yield. A comparative analysis of cohorts with PLD (n = 3589) versus ALD (n = 594) was conducted to identify differences in sample attrition.
Results: In a large PLD cohort study, we found that current commonly used eligibility criteria would exclude approximately 90% of patients, significantly limiting study generalizability. Substantial differences in sample attrition between PLD and ALD cohorts highlight the need for tailored criteria. The strength of scientific justification varied widely among criteria.
Conclusions: This study demonstrates the importance of using RWD to optimize eligibility criteria in PLD clinical trials. By providing insights into the balance between sample attrition and scientific justification, researchers can enhance trial feasibility, generalizability, and robustness. Our RWD sample demonstrates that researchers could substantially increase the sample yield from 10% to 64% by loosening restrictions on coinfections and misdiagnoses of chronic fatigue syndrome, fibromyalgia syndrome, and psychiatric conditions.

Category:

Lyme, research

Study Shows Worm-Like Self Assembling Entities in Bodies Who Got COVID Shots

https://slaynews.com/news/worm-like-self-assembling-entities-found-bodies-covid-vaccinated-study-warns/

‘Worm-Like Self-Assembling Entities’ Found in Bodies of Covid-Vaccinated, Study Warns

Frank Bergman
A disturbing study has reportedly found evidence of “self-assembling entities” in the bodies of people who received Covid mRNA “vaccines.”

Leading researchers in South Korea and Japan have issued a red alert after their bombshell study discovered the entities they described as “worm-like.”

According to the study, the “self-assembling entities” form “synthetic” nanostructures in the bodies of people who were “vaccinated” with Covid mRNA injections.

The shocking discovery of these “artificial constructions” was revealed in the long-term study’s recently published paper.

The study was led by South Korean obstetrician Dr. Young Mi Lee and Professor Daniel Broudy of Japan’s Okinawa Christian University.

Following their long-term study of Covid mRNA-vaccinated individuals, Lee and Broudy suggested that their main findings were the direct observation of both “self-assembling entities … of many different shapes,” and of “cellular toxicity” triggered by the Covid injections.

They noted that these discoveries were “especially” observed in blood and sperm cells.

In a Korean laboratory, using flu vaccine and normal saline as controls, the researchers incubated Pfizer and Moderna Covid mRNA “vaccines” in various fluids.

Important detail:

AstraZeneca and Novavax injections did not develop the “self-assembled” structures seen in the Pfizer and Moderna mRNA shots.

The findings resemble objects other doctors have been finding including ‘wires’ with frayed edges around which apparent ‘chips’ often appeared.  These wires were also found in the blood of the ‘vaccinated.’

Each injection was found to have ‘toxic effects on blood cells.’

Each shot had a distinct effect on blood cells:

  • Pfizer triggers “cellular collapse of white blood cells and damaged platelets.”
  • Moderna triggers rouleaux (stacking) of red blood cells.
  • Novavax causes the disintegration of the nucleus of white blood cells and some rouleaux of red blood cells..
  • AstraZeneca triggers “prominent rouleaux.”

Research also shows those who got the clot shot emit a fluorescent orange glow in their faces that is visible under UV light.  Those exposed to shedding emit the glow around their nose.  (See link for article)

______________

https://jamesroguski.substack.com/p/not-safe-and-not-effective?

NOT Safe And NOT Effective

This free online resource provides EVIDENCE that the mRNA platform is a biological weapon delivery system and its ongoing and expanded use constitutes a grievous crime against humanity.

Dec. 26, 2024

By James Roguski

Resource Center:

The purpose of this Resource Center is to make it easier for those who want to learn more to be able to access a wealth of information about the mRNA “vaccines” all in one location.

This Resource Center provides easy access to the best-of-the-best EVIDENCE showing that the Pfizer and Moderna mRNA “vaccines” should be removed from the marketplace IMMEDIATELY.

This series of articles/chapters will be published one per day beginning on December 26, 2024.

You may read all 26 articles/chapters now (before they are officially published) by clicking on the links below, but the comment section on each individual article will not be available until the scheduled publication date listed in parentheses below.

  1. NOT Safe And NOT Effective (this article) (Published: 12/26/24)
  2. An Open Letter to President Donald J. Trump (Published: 12/27/24)
  3. An Open Letter to Pam Bondi (12/28/24)
  4. An Open Letter to Robert F. Kennedy Jr. (12/29/24)
  5. Evidence of Military Control (12/30/24)
  6. A Timeline of Deception, Fraud and Coverup (12/31/24)
  7. Evidence From the Pfizer and Moderna Papers (1/1/25)
  8. Evidence of Harm (1/2/25)
  9. Evidence of Harm in VAERS (1/3/25)
  10. Evidence of Harm in V-safe (1/4/25)
  11. Evidence of Harm to Unborn and Nursing Infants and Their Mothers (1/5/25)
  12. Testimonies and “Anectodal Stories” (1/6/25)
  13. Evidence that the mRNA “Vaccines” are NOT effective (1/7/25)
  14. Evidence that the Spike Protein is Toxic (1/8/25)
  15. Evidence that the Lipid Nanoparticles are Toxic (1/9/25)
  16. Evidence of DNA Contamination (1/10/25)
  17. Evidence of Shedding (1/11/25)
  18. Evidence of Increased Morbidity and Mortality (1/12/25)
  19. Evidence From Autopsies (1/13/25)
  20. Evidence Regarding White Fibrous Structures (1/14/25)
  21. Evidence From Death Certificates (1/15/25)
  22. Word Crimes (1/16/25)
  23. Evidence of Fraudulent Misrepresentation (1/17/25)
  24. Movies and Books About the COVID-19 mRNA Injections (1/18/25)
  25. International Opposition to the mRNA Injections (1/19/25)
  26. How YOU Can Help (1/20/25)

If you have any questions or suggestions, please feel free to comment on this article or contact James Roguski directly at 310-619-3055 via phone, text, Signal, Telegram or WhatsApp.

The mRNA injectables are NOT “vaccines.”

THEY MUST BE TAKEN OFF THE MARKET IMMEDIATELY.

The mRNA injectable products from Pfizer and Moderna are gene-based biological weapons delivered by a lipid nanoparticle vector that was brought to you courtesy of Operation Warp Speed and the United States Department of Defense.

These biological weapons present a well-documented, imminent hazard to the health of everyone on earth. They have already killed thousands, possibly millions of people, and, due to a process known as shedding, the devastation that they cause extends even to those who have never actually received an mRNA injection.  (See link for article and videos)

______________

**Comment**

A new study finds COVID shots doubles your risk of post-COVID death, another paper shows COVID boosters increased mortality in nursing home residents and the effect was highly statistically significant after four weeks.

The U.S. Government Accountability Office (GAO) report found that ‘vaccine’ injury claims spiked 27X after COVID shot roll-out.

“If a child gets all the vaccines in the entire schedule, they get almost 13,000 micrograms of aluminum, and they get almost 600 micrograms of mercury, plus over 200 chemicals.  So that’s why they’ve never been proven to be safe.”  ~ Dr. Sherry Tenpenny

Category:

Activism, research, vaccines

Medical Detective #4: How to Survive in a Tick-Filled World

https://www.lymedisease.org/survive-in-tick-filled-world/

MEDICAL DETECTIVE #4: How to survive in a tick-filled world

This article was originally posted on Dr. Richard Horowitz’s Medical Detective Substack. You can find more helpful content by subscribing here. 

If I were to conjure up a global menace in a teeny-tiny package, I wouldn’t have to look far for inspiration. It’s already there, crawling down the legs of a deer or a dog and up the stalk of grasses or shrubs or plants in your garden, all primed and ready to latch on to your tender skin and take a nice big chomp!

It’s a tick-filled world and we’re stuck living in it.

And you know what’s making it worse? Climate change. The warmer the weather, the easier it is for ticks to breed. Increases in global temperatures increase the reproductive rates of insects, so we are seeing an explosion of not only pathogen-filled ticks, but also mosquitos that are potentially transmitting West Nile, Zika virus, Chikungunya, Dengue, other viruses and even malaria in the US.

The same pest-pocalypse is happening to other biting insects like fleas, mites, lice, etc. that can transmit a broad range of organisms, including Bartonella (more about this in future articles).

So remember, these insects, including ticks, may contain multiple bacteria, viruses, and parasites, and getting one bite can lead to more than one disease.

In fact, in my 40+ year experience treating chronically ill individuals, co-infections with multiple bacteria, viruses, and parasites are the rule, not the exception. And people usually end up getting multiple bites from ticks over their lifetime because these unbelievably annoying creatures are spreading rapidly and present in every corner of the globe (even Antarctica!).

Gruesome–but necessary–reading

Learning about how ticks live and feed makes for pretty gruesome reading.

Suffice to say that they go through four life stages: egg, six-legged larva, eight-legged nymph, and adult. The only course they have on their menu is blood, thanks to their bites on either animals or humans.

If they bite an animal that’s already carrying a pathogen, they can then transmit that bug to the next unlucky recipient of their cunning. Hopefully that won’t be you!

[Image from the Forest Service, USDA.]

And get this–some of these ticks are hermaphrodites, like the rapidly spreading Asian bush tick, Hemophylis Longicornis, which means they can reproduce without mating. This also means that they are reproducing more rapidly than other ticks.

Although they haven’t been proven yet to transmit some of the multiple infections now being found in them (Borrelia burgdorferi, i.e., Lyme disease, tularemia, Rickettsia like Rocky Mountain Spotted fever, Heartland, and Bourbon viruses), time will tell.

In Asia, these same ticks can cause alpha gal syndrome, the “red meat allergy” as well as SFTS (Severe Fever and Thrombocytopenia Syndrome), a potentially fatal illness.

Bottom line: if you get bitten, you want to know what kind of tick it is, and what pathogens it contains.

Different varieties in different regions

As you’ve unfortunately realized by now, there are many varieties of ticks that live in different areas of the U.S. (I’ll discuss this in an upcoming posting, but for now you can check this map: https://www.cdc.gov/ticks/data-research/facts-stats/geographic-distribution-of-tickborne-disease-cases.html.)

Not every tick is a carrier of a pathogen–only the black-legged deer tick can transmit Lyme Disease, for example–so getting bitten doesn’t automatically guarantee that you’ll get sick. But enough ticks are infected in this country and abroad, and can spread any or more of these 20 diseases with just one bite, as you can see from this CDC list:

Where Are Ticks Lurking?

Ticks are tenacious, and can be found even in urban environments you’d think would be free of them. According to the New York City Department of Health, for example, there were 3,323 (2,482 new ones and 741 positive ones from previous years) reported cases of Lyme disease in NYC residents in 2023. This is up from 2,524 cases in 2022.

There were also 77 reports of anaplasmosis and 116 of babesiosis in 2023. I suspect that these cases were picked up while in any of the city’s many parks, but who knows?

These numbers are likely gross underestimates of how bad the problem truly is, because several of the diseases we will be discussing can’t easily be picked up on standard blood tests, and doctors may not know to always look for them since some of the symptoms are non-specific and overlap other illnesses.

As I’ve said in earlier posts, last year alone, the CDC reported 476,000 cases of Lyme disease in the US, and their recent implementation of a revised case definition reported that case counts are rising where the incidence was 1.7 times the annual U.S. average in 2017–2019, an overall 68.5% increase, rising with patient age.

If you’re going outside to an environment where ticks are hiding—going to a park, hiking on trails in fields or forests, or while gardening, for example—follow these tips.

Tick Lookout Tips

  • Ticks can’t ‘officially’ fly, although static electricity from animals results in ticks being pulled by these electric fields across air gaps measuring several of their body lengths, resulting in leaps that one could almost define as flying. They also don’t jump, so they have to crawl from host to host as their primary means of attachment. They lurk. They wait. (This is called “questing.”)
  • The little monsters are clever enough to detect a potential host by sensing body heat, moisture, odors, or carbon dioxide; or by the vibrations of someone passing by. Although the deer tick (Ixodes scapularis in the northeastern US) or Ixodes pacificus (in the Pacific US), can sense your presence from 12 feet away and come running, some of these ticks like the lone star tick (Ambylomma Americanum) can sense your heat and carbon dioxide from up to 50 feet away. They will come after you to bite you from quite a distance, even if you are not in high grass or directly exposed.
  • As soon as they can climb onto where they aren’t wanted, they either latch on in one spot, or take their time wandering around your body where skin might be thinner and easier to bite.
  • So when you go outside, stay in the middle of any trails, away from tall grasses, branches, and leaves. Try not to brush up against any foliage. Ticks also like to quest in border areas in the yard or park and near bird feeders.
  • If you have a yard, keep the grass short. If you have a compost pile, or piles of leaves, stay out of them!
  • Don’t sit directly on the ground, on large stones or fallen logs, or on stone or brick walls.

This is part one of a two-part series about ticks originally published on Substack by Dr. Richard Horowitz. You can read the second part in the next Substack. 

See also:

“Medical Detective” series brings information you need to know

MEDICAL DETECTIVE #1: An overview of Lyme disease signs and symptoms 

MEDICAL DETECTIVE #2: How Will I Know If I Have Lyme Disease?

MEDICAL DETECTIVE #3: Let’s Talk About Lyme Rashes

Dr. Richard Horowitz has treated 13,000 Lyme and tick-borne disease patients over the last 40 years and is the best-selling author of  How Can I Get Better? and Why Can’t I Get Better? You can subscribe to read more of his work on Substack or join his Lyme-based newsletter for regular insights, tips, and advice.

______________

**Comment**

Dr. Horowitz is incorrect concerning ‘climate change’ making ticks and the diseases they carry worse.  Independent research has clearly shown ticks are on the move due to migrating birds and photoperiod (not to mention agents of our own government purposely infecting ticks with pathogens and then kicking boxes full of them out of airplanes).  Further, research blaming ‘climate change’ for every ill under the sun is based on biased research using an erroneous model.

Utilizing erroneous models was also clearly seen during the COVID psyop and continues to this day.

A bought out, biased media is also using corrupt data to spread this climate alarmism.

Due to highly sought after government grants, researchers have also fallen prey to conducting biased research, making claims that are not supported by data.

A train of articles have come out on how research and medicine have been hijacked and are completely driven by an unholy alliance with Industry, government, and University research facilities.  Besides being unethical, which should be troublesome on its own, it causes patient suffering.

‘Science’ is funded primarily by industry and this conflict of interest means there is little honest research being done.

Category:

Activism, Climate, research, Ticks